4.2 GEOGRAPHIC ANALYSIS: CELL SIGNALING MARKET, BY SIGNALING TYPE &
REGION (2017) 37
4.3 CELL SIGNALING MARKET, BY PATHWAY, 2017–2022 38
4.4 GEOGRAPHICAL SNAPSHOT OF THE CELL SIGNALING MARKET 38
5 MARKET OVERVIEW 39
5.1 INTRODUCTION 40
5.2 MARKET DYNAMICS 40
5.2.1 DRIVERS 41
5.2.1.1 Rising incidence of chronic diseases 41
5.2.1.2 Availability of funding for cell-based research 42
5.2.1.3 Technological advancements in cell-based research instruments 43
5.2.1.4 Growth of end-use industries 43
5.2.2 RESTRAINTS 44
5.2.2.1 High cost of cell signaling systems 44
5.2.2.2 Ethical issues related to embryonic stem cell signaling research 44
5.2.3 OPPORTUNITIES 45
5.2.3.1 Emerging markets 45
5.2.3.2 Emergence of microfluidics in cell biology research 45
5.2.4 CHALLENGES 46
5.2.4.1 Complexities related to antibody and reagent development 46
6 GLOBAL CELL SIGNALING MARKET, BY SIGNALING TYPE 47
6.1 INTRODUCTION 48
6.2 ENDOCRINE SIGNALING 49
6.3 PARACRINE SIGNALING 50